Vascular endothelial growth factor (VEGF) is a proangiogenic factor involved in HCC, and its overexpression in tumor tissues can be a useful prognostic factor after treatment, in patients with HCC. This evidence concerns the gene VEGFA and hepatocellular carcinoma.